Thompson Street Capital Partners Acquires LifeSpan Biosciences (LSBio)

September 17, 2018

Thompson Street Capital Partners (TSCP), a St. Louis-based private equity firm, has partnered with management to acquire Seattle-based LifeSpan Biosciences, Inc. (LSBio), a developer and e‑commerce distributor of antibodies, kits, proteins and related reagents for academic and pharmaceutical research. TSCP said it will support LSBio's strategy to expand its catalog and capabilities organically and via targeted acquisitions; terms were not disclosed.

Buyers
Thompson Street Capital Partners
Targets
LifeSpan Biosciences, Inc. (LSBio)
Industry
Biotechnology
Location
Washington, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.